Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026)
Zoetis' (ZTS) quarterly Depreciation & Amortization (CF) came in at $119.0 million in Q2 2026, down 4.03% year-over-year from $124.0 million in Q2 2025, and little changed quarter-over-quarter from $119.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Depreciation & Amortization (CF) for 15 consecutive years, with $119.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 4.03% year-over-year to $119.0 million in Q2 2026; TTM through Jun 2026 was $483.0 million, a 0.82% decrease from a year earlier, with the FY2025 full-year figure at $487.0 million, down 2.01% from the prior year.
- Depreciation & Amortization (CF) was $119.0 million for Q2 2026 at Zoetis, roughly flat from $119.0 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $127.0 million in Q2 2024 and troughed at $114.0 million in Q1 2022.
- A 5-year average of $121.1 million and a median of $121.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) gained 7.83% in 2023 and slipped 5.56% in 2025, its largest moves.
- Over 5 years, Depreciation & Amortization (CF) stood at $119.0 million in 2022, then rose by 5.88% to $126.0 million in 2023, then slipped by 2.38% to $123.0 million in 2024, then retreated by 1.63% to $121.0 million in 2025, then slipped by 1.65% to $119.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $119.0 million (Q2 2026), $119.0 million (Q1 2026), and $121.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.49 Bn | 40.29 Bn | 779.09 Mn | 41.05 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | 119.00 Mn |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 171.00 Mn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn | 13.35 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 470,621.00 |
| 6 | Zhengye Biotechnology Holding | 75.76 Mn | 68.66 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119.00 Mn |
| Mar 31, 2026 | 119.00 Mn |
| Dec 31, 2025 | 121.00 Mn |
| Sep 30, 2025 | 124.00 Mn |
| Jun 30, 2025 | 124.00 Mn |
| Mar 31, 2025 | 119.00 Mn |
| Dec 31, 2024 | 123.00 Mn |
| Sep 30, 2024 | 121.00 Mn |
| Jun 30, 2024 | 127.00 Mn |
| Mar 31, 2024 | 126.00 Mn |
| Dec 31, 2023 | 126.00 Mn |
| Sep 30, 2023 | 124.00 Mn |
| Jun 30, 2023 | 121.00 Mn |
| Mar 31, 2023 | 120.00 Mn |
| Dec 31, 2022 | 119.00 Mn |
| Sep 30, 2022 | 115.00 Mn |
| Jun 30, 2022 | 117.00 Mn |
| Mar 31, 2022 | 114.00 Mn |
| Dec 31, 2021 | 117.00 Mn |
| Sep 30, 2021 | 110.00 Mn |